alnylam
The Associate Scientist II will join Alnylam's RNAi Discovery team in Cambridge, MA, focusing on quality control of single‑stranded RNA and formulation of siRNA test articles. The role involves preparing analytical samples, performing HPLC, LCMS, UV‑VIS, and bacterial endotoxin testing, and presenting data to internal research groups.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
24% above the average for this role
Summer Intern - Bioanalytics (Analytical Research)
GovernmentJobs
Associate Scientist III, Quality Control, IPC Testing
Arrowhead Pharmaceuticals
Bench Scientist
Global Channel Management
Scientist – Analytical Development
Syngene International Limited
Associate Scientist
Alcami Corporation
Biopharmaceutical Chemist
Eurofins